Pesquisas alternativas:
failed phase » failed case (Expandir a Pesquisa), labeled phase (Expandir a Pesquisa), enabled phase (Expandir a Pesquisa)
phase 1 » phase _ (Expandir a Pesquisa), phase 2 (Expandir a Pesquisa)
failed phase » failed case (Expandir a Pesquisa), labeled phase (Expandir a Pesquisa), enabled phase (Expandir a Pesquisa)
phase 1 » phase _ (Expandir a Pesquisa), phase 2 (Expandir a Pesquisa)
1
Por Kawasaki, Daizo, Fukunaga, Masashi, Nakata, Tsuyoshi, Kato, Masaaki, Ohkubo, Nobukazu
Publicado no J Atheroscler Thromb (2017)
“... out of a total of 219 lesions. From May 2013 to June 2016 (phase 1), the bi-directional approach...”Publicado no J Atheroscler Thromb (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“... to the emerging field of safety pharmacology. It is concluded that suppression of phase 2 as well as phase 1 VF...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Giannuzzi, Viviana, Landi, Annalisa, Bosone, Enrico, Giannuzzi, Floriana, Nicotri, Stefano, Torrent-Farnell, Josep, Bonifazi, Fedele, Felisi, Mariagrazia, Bonifazi, Donato, Ceci, Adriana
Publicado no BMJ Open (2017)
“... authorisation failures), 50% reached phase II, 47% reached phase III and 3% reached phase I, while in the second...”Publicado no BMJ Open (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por PeiJian Peng, XueQing Ou, Hai Liao, YuMeng Liu, SiYang Wang, ZhiBin Cheng, Zhong Lin
Publicado em 2016-05-01
“.... This phase II study was designed to evaluate the efficacy and safety of gemcitabine plus S-1 (GS...”Publicado em 2016-05-01
Obter o texto integral
Artigo
5
Por Peng, PeiJian, Ou, XueQing, Liao, Hai, Liu, YuMeng, Wang, SiYang, Cheng, ZhiBin, Lin, Zhong
Publicado no Ther Adv Med Oncol (2016)
“.... This phase II study was designed to evaluate the efficacy and safety of gemcitabine plus S-1 (GS...”Publicado no Ther Adv Med Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Elharrar, Xavier, Barbolosi, Dominique, Ciccolini, Joseph, Meille, Christophe, Faivre, Christian, Lacarelle, Bruno, André, Nicolas, Barlesi, Fabrice
Publicado no BMC Cancer (2016)
“... metronomic protocol could lead to a better safety and efficacy profile. DESIGN: This phase Ia/Ib trial...”Publicado no BMC Cancer (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Personeni, Nicola, Pressiani, Tiziana, Santoro, Armando, Rimassa, Lorenza
Publicado no Drugs Context (2018)
“... CELESTIAL trial. As HCC seems to be an attractive target for immunotherapy, a phase 1/2 trial reported...”Publicado no Drugs Context (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Younes, Anas, Santoro, Armando, Shipp, Margaret, Zinzani, Pier Luigi, Timmerman, John M, Ansell, Stephen, Armand, Philippe, Fanale, Michelle, Ratanatharathorn, Voravit, Kuruvilla, John, Cohen, Jonathon B, Collins, Graham, Savage, Kerry J, Trneny, Marek, Kato, Kazunobu, Farsaci, Benedetto, Parker, Susan M, Rodig, Scott, Roemer, Margaretha GM, Ligon, Azra H, Engert, Andreas
Publicado no Lancet Oncol (2016)
“... and enables tumour cells to evade immune surveillance. A phase 1b study showed that nivolumab, a PD-1-blocking...”Publicado no Lancet Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Kumthekar, Priya, Raizer, Jeffrey, Cavaliere, Robert, Devoe, Craig, Jensen, Randy, Stieber, Volker, Runk, Tina, Grewal, Jai, Brownell, Elise, Zukiwski, Alex, Proniuk, Stefan, Arnold, Susanne, Vredenburgh, James
Publicado no Neuro Oncol (2019)
“... and lipophilicity than current drugs in this class. Safety and efficacy of AR-67 were evaluated in a Phase 2 study...”Publicado no Neuro Oncol (2019)
Obter o texto integral
Obter o texto integral
Artigo
10
“... subjective or objective neurologic symptoms. Overall, blood pressure and heart rate increased 1–4 hr after...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
The efficacy and safety of endovascular recanalization of occluded large cerebral arteries during...
Por Chen, Kangning, Hou, Xianhua, Zhou, Zhenhua, Li, Guangjian, Liu, Qu, Gui, Li, Hu, Jun, Shi, Shugui
Publicado no Stroke Vasc Neurol (2017)
“... with cerebral infarction caused by IAO in the subacute phase. After the procedure, 12 cases were recanalized...”Publicado no Stroke Vasc Neurol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Phan, Thanh G., Ma, Henry, Lim, Rebecca, Sobey, Christopher G., Wallace, Euan M.
Publicado no Front Neurol (2018)
“..., even when administered 1–3 days after the onset of stroke. METHODS: We now propose an open label Phase...”Publicado no Front Neurol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Wilson, Eleanor M., Kattakuzhy, Sarah, Sidharthan, Sreetha, Sims, Zayani, Tang, Lydia, McLaughlin, Mary, Price, Angie, Nelson, Amy, Silk, Rachel, Gross, Chloe, Akoth, Elizabeth, Mo, Hongmei, Subramanian, G. Mani, Pang, Phillip S., McHutchison, John G., Osinusi, Anu, Masur, Henry, Kohli, Anita, Kottilil, Shyam
Publicado no Clin Infect Dis (2016)
“... and safety of ledipasvir (LDV) and sofosbuvir (SOF) for 12 weeks in HCV genotype-1 (GT-1) patients who failed...”Publicado no Clin Infect Dis (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Yong-Pyo Lee, Sung Yong Oh, Kwang Min Kim, Se-Il Go, Jung Hoon Kim, Seok Jae Huh, Jung Hun Kang, Jun Ho Ji
Publicado em 2022-04-01
“... and safety of a second-line modified dose of FOLFIRINOX (mFOLFIRINOX) for patients who had failed first-line...”Publicado em 2022-04-01
Obter o texto integral
Artigo
15
Por Tareen, Basir, Summers, Jack L., Jamison, James M., Neal, Deborah R., McGuire, Karen, Gerson, Lowell, Diokno, Ananias
Publicado em 2008
“... 1 death occurred after 14 months of treatment. Conclusion: Apatone showed promise in delaying...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Artigo
16
Por Kim, Jae‐Joon, Ryu, Min‐Hee, Yoo, Changhoon, Beck, Mo Youl, Ma, Jung Eun, Kang, Yoon‐Koo
Publicado no Oncologist (2019)
“... period has also been noted in some patients. Therefore, we conducted this phase II trial to evaluate...”Publicado no Oncologist (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Manns, M P, Wedemeyer, H, Singer, A, Khomutjanskaja, N, Dienes, H P, Roskams, T, Goldin, R, Hehnke, U, Inoue, H
Publicado em 2012
“...Chronic hepatitis C patients often fail to respond to interferon-based therapies. This phase III...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Burmester, Gerd R, Feist, E, Kellner, H, Braun, J, Iking-Konert, C, Rubbert-Roth, A
Publicado em 2010
“... in the phase III trial programme. Serious infections were observed in 3.1% of patients. CONCLUSIONS...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por van der Noll, Ruud, Marchetti, Serena, Steeghs, Neeltje, Beijnen, Jos H, Mergui-Roelvink, Marja W J, Harms, Emmy, Rehorst, Harriet, Sonke, Gabe S, Schellens, Jan H M
Publicado no Br J Cancer (2015)
“.... METHODS: Patients had first participated in a phase I study of olaparib combined with carboplatin...”Publicado no Br J Cancer (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Zhao, Jian, Lei, Junmei, Yu, Junyan, Zhang, Chengyan, Song, Xuefeng, Zhang, Ninggang, Wang, Yusheng, Zhang, Suxiang
Publicado no Invest New Drugs (2019)
Assuntos:
“...Phase II Studies...”Publicado no Invest New Drugs (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo